SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-017124
Filing Date
2024-05-15
Accepted
2024-05-15 16:59:51
Documents
60
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20240331_10q.htm   iXBRL 10-Q 925312
2 EXHIBIT 10.1 ex_674656.htm EX-10.1 74901
3 EXHIBIT 10.2 ex_674657.htm EX-10.2 31049
4 EXHIBIT 31.1 ex_657129.htm EX-31.1 15865
5 EXHIBIT 32.1 ex_657131.htm EX-32.1 7384
  Complete submission text file 0001437749-24-017124.txt   4893978

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA wint-20240331.xsd EX-101.SCH 48066
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20240331_cal.xml EX-101.CAL 25915
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240331_def.xml EX-101.DEF 359898
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240331_lab.xml EX-101.LAB 292828
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240331_pre.xml EX-101.PRE 375780
64 EXTRACTED XBRL INSTANCE DOCUMENT wint20240331_10q_htm.xml XML 533153
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 24952273
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)